Search in:

Expert Opinion on Drug Safety Volume 8, 2009 - Issue 4

Submit an article Journal homepage

520

Views

CrossRef citations to date

Altmetric

Drug Safety Evaluations

Long-term safety of tacrolimus ointment in atopic dermatitis

Anita Remitz Specialist in dermatology Helsinki University Central Hospital, Skin and Allergy Hospital, Department of Dermatology, Helsinki, Finland +358 9 47186482; +358 9 4718651; [email protected]

, MD PhD &

Sakari Reitamo Specialist in dermatology Helsinki University Central Hospital, Skin and Allergy Hospital, Department of Dermatology, Helsinki, Finland +358 9 47186482; +358 9 4718651; [email protected]

, MD PhD

Pages 501-506 | Published online: 12 May 2009

Cite this article
https://doi.org/10.1517/14740330902969441

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Goto T, Kino T, Hatanaka K, et al. Discovery of FK-506, a novel immunosuppressant isolated from Sterptomyces tsukubaensis. Transpl Proc 1987;19(Suppl 6):4-8
PubMed Web of Science ®Google Scholar
Lauerma AI, Maibach HI, Granlund H, et al. Unhibition of contact allergy reaction by topical FK 506. Lancet 1992;340:556
PubMed Web of Science ®Google Scholar
Nakagawa H, Etoh T, Ishibashi Y, et al. Tacrolimus ointment for atopic dermatitis. Lancet 1994;344:883
PubMed Web of Science ®Google Scholar
Ruzicka T, Bieber T, Schöpf E, et al. A short-term trial with tacrolimus ointment for atopic dermatitis. N Engl J Med 1997;337:816-21
PubMed Web of Science ®Google Scholar
Reitamo S. Tacrolimus. A new topical immunomodulatory therapy for atopic dermatitis. J Allergy Clin Immunol 2001;107:445-8
PubMed Web of Science ®Google Scholar
Undre AN. Pharmacokinetics of tacrolimus ointment. In: Ruzicka T, Reitamo S, editors, Tacrolimus ointment, Springer, Berlin; 2004. p. 99-110
Google Scholar
O'Regan GM, Sandilands A, McLean WH, et al. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008;122:689-93
PubMed Web of Science ®Google Scholar
Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin gene expression. J Allergy Clin Immunol 2007;1120:150-5
Web of Science ®Google Scholar
Rubins A, Gutmane R, Valdmane N, et al. Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis. J Invest Dermatol 2005;125:68-71
PubMed Web of Science ®Google Scholar
Harper J, Smith C, Rubins A, et al. A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis. J Invest Dermatol 2005;124:695-9
PubMed Web of Science ®Google Scholar
Reitamo S, Mandelin JM, Rubins A, et al. Pharmacokinetics of tacrolimus ointment in infants of 3-24 months of age. Int J Dermatol 2009;48:348-55
PubMed Web of Science ®Google Scholar
Luger TA, Steinhoff M, Remitz A, Reitamo S. Topical calcineurin inhibitors. In: Reitamo S, Luger TA, Steinhoff M, editors, Textbook of atopic dermatitis. Informa Healthcare, London 2008. p. 221-45
Google Scholar
Reitamo S, Harper J, Bos J, et al. 0.03% tacrolimus ointment applied once or twice daily is more effacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis. Br J Dermatol 2004;150:554-62
PubMed Web of Science ®Google Scholar
Reitamo S, Wollenberg A, Schöpf E, et al. Safety and efficacy of 1 year of tacrolimus ointment in adults with atopic dermatitis. Arch Dermatol 2000;136:999-1006
PubMed Web of Science ®Google Scholar
Kang S, Lucky AW, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001;44(1 Suppl):S58-64
PubMed Web of Science ®Google Scholar
Reitamo S, Ortonne JP, Sand C, et al. Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study. Acta Derm Venereol 2007;87:406-12
PubMed Web of Science ®Google Scholar
Remitz A, Harper J, Rustin M, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Acta Derm Venereol 2007;87:54-61
PubMed Web of Science ®Google Scholar
Hanifin JM, Paller AS, Eichenfield L, et al. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol 2005;53(2 Suppl 2):S186-94
PubMed Web of Science ®Google Scholar
Reitamo S, Rustin M, Harper J, et al. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment. Br J Dermatol 2008;159:942-51
PubMed Web of Science ®Google Scholar
Berth-Jones J, Damstra RJ, Golsch S, et al. Twice weekly fluticasone propionate added to emollient maintenace treatment to reduce risk of relapse in atopic dermatitis: randomized, double-blind, parallel group study. Br Med J 2003;326:1367-70
PubMed Web of Science ®Google Scholar
Wollenberg A, Reitamo S, Girolomoni G, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008;63:742-50
Web of Science ®Google Scholar
ThaÇi D, Reitamo S, Gonzalez Ensenat MA, et al. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Br J Dermatol 2008;159:1348-56
PubMed Web of Science ®Google Scholar
Reitamo S, Remitz A, Haahtela T. Hit early and hit hard in atopic dermatitis and not only in asthma. Allergy 2009;64:503-4
PubMed Web of Science ®Google Scholar
Breneman D, Fleischer AB Jr, Abramovits W, et al. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment. J Am Acad Dermatol 2008;58:990-9
PubMed Web of Science ®Google Scholar
Paller AS, Eichenfield LF, Kirsner RS, et al. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Pediatrics 2008;122:e1210-8
PubMed Web of Science ®Google Scholar
Reitamo S, Van Leent EJ, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002;109:539-46
PubMed Web of Science ®Google Scholar
Reitamo S, Rustin M, Ruzicka T, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002;109:547-55
PubMed Web of Science ®Google Scholar
Doss N, Reitamo S, Dubertret L, et al. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. Br J Dermatol, published online April 16 2009; doi:10.1111/j.1365-2133.2009.09143x
Google Scholar
Reitamo S, Ortonne JP, Sand C, et al. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol 2005;152:1282-9
PubMed Web of Science ®Google Scholar
Allen A, Siegfried E, Silverman R, et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 2001;137:747-50
PubMed Web of Science ®Google Scholar
Bieber T. Atopic dermatitis. N Engl J Med 2008;358:1483-94
PubMed Web of Science ®Google Scholar
Mandelin JM, Remitz A, Virtanen HM, Reitamo S. Recall-antigen reactions in patients with atopic dermatitis treated with tacrolimus ointment for one year. J Allergy Clin Immunol 2008;121:777-9
PubMed Web of Science ®Google Scholar
Remitz A, Kyllönen H, Granlund H, Reitamo S. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol 2001;107:196-7
PubMed Web of Science ®Google Scholar
Ständer S, Ständer H, Seeliger S, et al. Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol 2007;156:1020-6
PubMed Web of Science ®Google Scholar
Fleischer AB Jr, Ling M, Eichenfield L, et al. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. J Am Acad Dermatol 2002;47:562-70
PubMed Web of Science ®Google Scholar
Arellano FM, Wentworth CE, Arana A, et al. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol 2007;127:808-16
PubMed Web of Science ®Google Scholar
Reitamo S, Rissanen J, Remitz A, et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998;111:396-8
PubMed Web of Science ®Google Scholar
Kyllönen H, Remitz A, Mandelin JM, et al. Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis. Br J Dermatol 2004;150:1174-81
PubMed Web of Science ®Google Scholar
Sugiura H, Uehara M, Hoshino N, Yamaji A. Long-term efficacy of tacrolimus ointment for recalcitrant facial erythema resistant to topical corticosteroids in adult patients with atopic dermatitis. Arch Dermatol 2000;136:1062-3
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Long-term safety of tacrolimus ointment in atopic dermatitis

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term safety of tacrolimus ointment in atopic dermatitis

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date